ANI Pharmaceuticals, Inc (ANIP)

Etorro trading 970x250

About ANI Pharmaceuticals, Inc

ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract manufacturing for other pharmaceutical companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was founded in 2001 and is headquartered in Baudette, Minnesota. Address: 210 Main Street West, Baudette, MN, United States, 56623

ANI Pharmaceuticals, Inc News and around…

Latest news about ANI Pharmaceuticals, Inc (ANIP) common stock and company :

Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
01 Oct, 2021 FinancialContent

Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug ...

7 Overbought Stocks to Be Very Careful of Right Now
01 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips While the market rally this year has been incredible, worrying developments suggest investors should watch out for overbought stocks. The post 7 Overbought Stocks to Be Very Careful of Right Now appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Analysts Predict 24% Gains Ahead For PSCH
21 Sep, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco S&P SmallCap Health Care ETF (PSCH), we found that the implied analyst target price for the ETF based upon its underlying holdings is $226.60 per unit.

ANI Pharmaceuticals to Present at Cantor Virtual Global Healthcare Conference 2021
20 Sep, 2021 FinancialContent

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Cantor Virtual Global Healthcare Conference 2021 as follows:

ANI Pharmaceuticals Announces Launch of Nebivolol Tablets
17 Sep, 2021 FinancialContent

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced the launch of Nebivolol Tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg.

Looking Into ANI Pharmaceuticals's Return On Capital Employed
09 Sep, 2021 FinancialContent

Benzinga Pro data, ANI Pharmaceuticals (NASDAQ:ANIP) reported Q2 sales of $48.62 million. Earnings fell to a loss of $15.55 million, ...

Is ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Shareholder Ownership Skewed Towards Insiders?
03 Sep, 2021 Yahoo! Finance

If you want to know who really controls ANI Pharmaceuticals, Inc. ( NASDAQ:ANIP ), then you'll have to look at the...

ANI Pharma's Purified Cortrophin Gel Application Under FDA Review
31 Aug, 2021 FinancialContent

TheFDA has acceptedANI Pharmaceuticals Inc's(NASDAQ: ANIP) supplemental marketing application for Purified ...

ANI Pharmaceuticals Announces FDA Acceptance of Purified Cortrophin® Gel Supplemental New Drug Application for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis, and Nephrotic Sy
31 Aug, 2021 FinancialContent

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq:ANIP) today announced that the Company’s supplemental New Drug Application (“sNDA”) for Purified Cortrophin® Gel (“Cortrophin Gel”) has been accepted by the U.S. Food and Drug Administration (“FDA”) for review.

ANI Pharmaceuticals Announces FDA Acceptance of Purified Cortrophin® Gel Supplemental New Drug Application for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis, and Nephrotic Syndrome
31 Aug, 2021 Yahoo! Finance

BAUDETTE, Minn., August 31, 2021--ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq:ANIP) today announced that the Company’s supplemental New Drug Application ("sNDA") for Purified Cortrophin® Gel ("Cortrophin Gel") has been accepted by the U.S. Food and Drug Administration ("FDA") for review.

ANI Pharmaceuticals, inc (ANIP) Q2 2021 Earnings Call Transcript
06 Aug, 2021 FinancialContent

ANIP earnings call for the period ending June 30, 2021.

ANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Surpass Estimates
06 Aug, 2021 Yahoo! Finance

ANI (ANIP) delivered earnings and revenue surprises of 3.08% and 1.73%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Recap: ANI Pharmaceuticals Q2 Earnings
06 Aug, 2021 FinancialContent

Shares of ANI Pharmaceuticals (NASDAQ:ANIP) were unchanged after the company reported Q2 results. Quarterly ...

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
06 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

ANI Pharmaceuticals Reports Second Quarter 2021 Results
06 Aug, 2021 FinancialContent

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced business highlights and financial results for the three and six months ended June 30, 2021.

Earnings Scheduled For August 6, 2021
06 Aug, 2021 FinancialContent

Companies Reporting Before The Bell • Liberty Braves Group (NASDAQ:BATRA) is projected to report quarterly loss at ...

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
01 Aug, 2021 FinancialContent

Biotech stocks showed a lack of direction in the week endingJuly 30 amid earnings releases from big pharma companies. Most ...

Analysts Estimate ANI Pharmaceuticals (ANIP) to Report a Decline in Earnings: What to Look Out for
30 Jul, 2021 Yahoo! Finance

ANI (ANIP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ANI Pharmaceuticals to Discuss Second Quarter 2021 Financial Results on August 6, 2021
22 Jul, 2021 FinancialContent

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2021 financial results on Friday, August 6, 2021.

Analysts Forecast 14% Gains Ahead For The Holdings of SLYV
19 Jul, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR— S&P 600 Small Cap Value ETF (SLYV), we found that the implied analyst target price for the ETF based upon its underlying holdings is $91.42 per unit.

ANI Pharmaceuticals Announces Refiling of Cortrophin sNDA with FDA
06 Jul, 2021 FinancialContent

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that the Company has re-filed its supplemental new drug application (“sNDA”) for Cortrophin® Gel with the U.S. Food and Drug Administration (“FDA”).

Rising drug prices continue to hit seniors
06 Jul, 2021 FinancialContent

These prices are growing faster than the overall core inflation rate

ANI Pharmaceuticals' (NASDAQ:ANIP) Shareholders Are Down 51% On Their Shares
05 Jul, 2021 Yahoo! Finance

If you love investing in stocks you're bound to buy some losers. Long term ANI Pharmaceuticals, Inc. ( NASDAQ:ANIP...

ANI Pharmaceuticals Inc (ANIP) Fell Out Of Favor With Hedge Funds
30 Jun, 2021 Yahoo! Finance

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 866 13F filings submitted by hedge funds and prominent investors. These filings show these funds’ portfolio positions as of March 31st, 2020. […]

ANI Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference 2021
15 Jun, 2021 FinancialContent

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Raymond James Human Health Innovation Conference 2021 as follows:

ANI Pharmaceuticals Announces Details of 2021 Virtual Annual Meeting of Stockholders
01 Jun, 2021 FinancialContent

ANI Pharmaceuticals, Inc. (“ANI“ or the “Company“) (Nasdaq: ANIP) today announced log-in details for its 2021 Virtual Annual Meeting of Stockholders to be held on June 2, 2021, beginning at 10 a.m. Eastern Time.

ANI Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference 2021
27 May, 2021 FinancialContent

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Conference 2021 as follows:

New Strong Sell Stocks for May 24th
24 May, 2021 Yahoo! Finance

ANIP, BHVN, FVRR, KBAL, and PLNT have been added to the Zacks Rank #5 (Strong Sell) List on May 24, 2021

Analysts Expect 21% Gains Ahead For PSCH
13 May, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco S&P SmallCap Health Care ETF (PSCH), we found that the implied analyst target price for the ETF based upon its underlying holdings is $213.14 per unit.

ANI Pharmaceuticals Inc (ANIP) Q1 2021 Earnings Call Transcript
07 May, 2021 FinancialContent

ANIP earnings call for the period ending March 31, 2021.

ANI Pharmaceuticals, Inc (ANIP) is a NASDAQ Common Stock listed in , ,

970x250